A new exploratory study will evaluate the safety of Anktiva in patients with long COVID, with secondary and exploratory ...

In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), ...

The Phase II EvolvE trial (NCT05774184) confirmed barzolvolimab’s mechanism of action but showed no measurable improvement in dysphagia symptoms or esophageal inflammation in patients with ...

An overview of how recent funding reductions are reshaping clinical trial operations, from site sustainability and patient recruitment to trial design and long-term strategy.